Newsletter | October 18, 2021

10.18.21 -- Are You Ready For A Biotech M&A Boom?

Exclusive Articles
How To Prepare For A Remote Regulatory Inspection
Remote regulatory inspections were a significant change that occurred during the COVID-19 crisis. Considering that these will continue even after the pandemic, we’ve compiled some tips on how to prepare for and what to expect from a remote inspection.
Do Strategic Partnerships Meet Outsourcers Expectations?

ISR’s CDMO Outsourcing Models report dives into three approaches to contracting manufacturing work, the motivations behind using each approach, and details on which methods earn the greatest satisfaction among users.

Gearing Up For A Biotech M&A Boom

Biotech M&A was slow in the first half of 2021, but that may be changing, with emerging trends indicating that a biotech M&A boom could be on the horizon. If your biotech is hoping to be acquired by a larger pharma company, it’s crucial that you start preparing now.

Beyond The Printed Page
CEO Advice From A 30-Year Pharma Veteran

Lisa Conte, founder of Jaguar Health, shares her thoughts on becoming a biopharmaceutical company CEO and the approach taken to create the proper corporate culture.

How Efforts In Gene Therapy Benefitted Rapid COVID-19 Vaccine Development

In this executive virtual roundtable (EVR) component, Bryan Butman, Ph.D., head of CMC, Precigen, provides perspective on how early work in gene therapy benefitted the development of viral vector vaccines for COVID-19. 

October 2021 Digital Edition

Inside you will find more on:

  • Exclusive Top Executive Interviews
  • Industry Research
  • Finance-Related Topics
  • Leadership Tips

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.